BCAX
Bicara Therapeutics Inc.
Company overview
- Market capitalization
- $1.24B
- Employees
- 103
- Latest publication
- 2026-09-29
About Bicara Therapeutics Inc.
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 45,773,000USD | 47,500,000USD | 32,990,000USD | 5,817,000USD | 24,798,000USD | 34,333,000USD | 19,883,000USD | 15,864,000USD |
| Income Tax Expense | 61,000USD | -52,000USD | 53,000USD | 40,000USD | 52,000USD | 72,000USD | 186,000USD | — |
| Net Income | -55,375,000USD | -56,211,000USD | -37,386,000USD | -36,330,000USD | -27,388,000USD | -36,846,000USD | -20,957,000USD | -17,481,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Selling General Administrative | — | 12,742,000USD | 8,132,000USD | 7,701,000USD | 7,220,000USD | 7,455,000USD | 6,754,000USD | 4,764,000USD |
| Total Operating Expenses | — | 60,242,000USD | 41,122,000USD | 40,676,000USD | 32,018,000USD | 41,788,000USD | 26,637,000USD | 20,628,000USD |
| Operating Income | — | -60,242,000USD | -41,122,000USD | -40,676,000USD | -32,018,000USD | -41,788,000USD | -26,637,000USD | -20,628,000USD |
| Interest Income | — | 4,083,000USD | 3,789,000USD | 4,386,000USD | 4,682,000USD | 5,014,000USD | 5,866,000USD | 3,147,000USD |
| Net Interest Income | — | 4,083,000USD | 3,789,000USD | 4,386,000USD | 4,682,000USD | 5,014,000USD | 5,866,000USD | 3,147,000USD |
| Income Before Tax | — | -56,159,000USD | -37,333,000USD | -36,290,000USD | -27,336,000USD | -36,774,000USD | -20,771,000USD | -17,481,000USD |
| Tax Provision | — | 52,000USD | 53,000USD | 40,000USD | 52,000USD | 72,000USD | 186,000USD | 0USD |
| Net Income From Continuing Ops | — | -56,211,000USD | -37,386,000USD | -36,330,000USD | -27,388,000USD | -36,846,000USD | -20,957,000USD | -17,481,000USD |
| Ebitda | — | -60,242,000USD | -41,122,000USD | -36,234,000USD | -31,999,000USD | -41,769,000USD | -26,622,000USD | -20,613,000USD |
| Reconciled Depreciation | — | 44,000USD | 43,000USD | 24,000USD | 19,000USD | 19,000USD | 15,000USD | 15,000USD |
| Total Other Income Expense Net | — | 4,083,000USD | 3,789,000USD | 4,386,000USD | 4,682,000USD | 5,014,000USD | 5,866,000USD | 3,147,000USD |
| Ebit | — | — | -41,133,000USD | -36,290,000USD | -32,018,000USD | -41,788,000USD | -26,637,000USD | -20,628,000USD |
| Depreciation And Amortization | — | — | 11,000USD | 56,000USD | 19,000USD | 19,000USD | 15,000USD | 15,000USD |
| Unclassified Operating Expenses | — | — | — | 27,158,000USD | — | — | — | — |
| Cost Of Revenue | — | — | — | — | 19,000USD | 19,000USD | 15,000USD | 15,000USD |
| Gross Profit | — | — | — | — | -19,000USD | -19,000USD | -15,000USD | -15,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD |
| Research Development | 125,096,000USD | 63,619,000USD | 30,617,000USD | 31,312,000USD |
| Selling General Administrative | 30,508,000USD | 18,770,000USD | 9,272,000USD | 6,344,000USD |
| Total Operating Expenses | 155,604,000USD | 82,389,000USD | 39,889,000USD | 37,656,000USD |
| Operating Income | -155,604,000USD | -82,389,000USD | -39,889,000USD | -37,656,000USD |
| Interest Income | 17,871,000USD | 14,581,000USD | 1,314,000USD | 4,000USD |
| Net Interest Income | 17,871,000USD | 14,581,000USD | 1,314,000USD | -108,000USD |
| Income Before Tax | -137,733,000USD | -67,808,000USD | -51,980,000USD | -37,844,000USD |
| Income Tax Expense | 217,000USD | 187,000USD | 5,000USD | 1,000USD |
| Tax Provision | 217,000USD | 187,000USD | 5,000USD | 1,000USD |
| Net Income | -137,950,000USD | -67,995,000USD | -51,985,000USD | -37,845,000USD |
| Net Income From Continuing Ops | -137,950,000USD | -67,995,000USD | -51,985,000USD | -37,845,000USD |
| Ebit | -155,709,000USD | -82,389,000USD | -39,889,000USD | -37,732,000USD |
| Ebitda | -155,604,000USD | -82,333,000USD | -39,870,000USD | -37,722,000USD |
| Depreciation And Amortization | 105,000USD | 56,000USD | 19,000USD | 10,000USD |
| Reconciled Depreciation | 105,000USD | 56,000USD | 19,000USD | 10,000USD |
| Total Other Income Expense Net | 17,871,000USD | 14,581,000USD | -12,091,000USD | -188,000USD |
| Cost Of Revenue | — | 56,000USD | 19,000USD | 10,000USD |
| Gross Profit | — | -56,000USD | -19,000USD | -10,000USD |
| Interest Expense | — | — | 0USD | 112,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 512,243,000USD | 553,599,000USD | 430,994,000USD | 424,688,000USD | 453,587,000USD | 478,077,000USD | 569,195,000USD | 524,173,000USD |
| Cash And Equivalents | 96,599,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 497,259,000USD | 539,753,000USD | 414,801,000USD | 290,167,000USD | 436,606,000USD | 462,065,000USD | 489,711,000USD | 520,758,000USD |
| Short Term Investments | 400,660,000USD | 216,291,000USD | 318,116,000USD | 118,494,000USD | — | — | 0USD | — |
| Total Current Assets | 503,820,000USD | 544,915,000USD | 422,053,000USD | 297,372,000USD | 444,391,000USD | 470,754,000USD | 502,533,000USD | 521,514,000USD |
| Other Current Assets | 6,561,000USD | 5,162,000USD | 7,252,000USD | 7,205,000USD | 7,785,000USD | 8,689,000USD | 12,822,000USD | 756,000USD |
| Other Non Current Assets | 6,910,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 43,475,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 43,475,000USD | 39,340,000USD | 28,949,000USD | 21,028,000USD | 17,227,000USD | 19,120,000USD | 17,990,000USD | 14,481,000USD |
| Total Stockholder Equity | 468,768,000USD | 513,958,000USD | 401,452,000USD | 402,780,000USD | 435,196,000USD | 458,957,000USD | 491,875,000USD | 509,555,000USD |
| Total Equity Including Noncontrolling Interest | 468,768,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,513,000USD | 1,774,000USD | 2,031,000USD | 2,104,000USD | 2,354,000USD | 688,000USD | 845,000USD | 544,000USD |
| Short Term Debt | 1,163,000USD | 1,140,000USD | 1,117,000USD | 1,095,000USD | 1,074,000USD | 591,000USD | 607,000USD | 308,000USD |
| Common Stock | 8,000USD | 8,000USD | — | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -470,613,000USD | -415,177,000USD | -358,966,000USD | -321,580,000USD | -285,250,000USD | -257,862,000USD | -221,016,000USD | -200,059,000USD |
| Accumulated Other Comprehensive Income | -567,000USD | -243,000USD | — | -136,000USD | 0USD | — | — | 0USD |
| Total Liab | — | 39,641,000USD | 29,542,000USD | 21,908,000USD | 18,391,000USD | 19,120,000USD | 77,320,000USD | 14,618,000USD |
| Other Current Liab | — | 32,012,000USD | 22,317,000USD | 16,930,000USD | 13,242,000USD | 15,789,000USD | 12,875,000USD | 12,211,000USD |
| Capital Stock | — | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD |
| Cash | — | 323,462,000USD | 96,685,000USD | 171,673,000USD | 436,606,000USD | 462,065,000USD | 489,711,000USD | 520,758,000USD |
| Net Debt | — | -322,021,000USD | -94,975,000USD | -169,698,000USD | -434,368,000USD | -461,474,000USD | -488,973,000USD | -520,313,000USD |
| Short Long Term Debt Total | — | 1,441,000USD | 1,710,000USD | 1,975,000USD | 2,238,000USD | 591,000USD | 738,000USD | 445,000USD |
| Accounts Payable | — | 6,188,000USD | 5,515,000USD | 3,003,000USD | 2,911,000USD | 2,740,000USD | 4,508,000USD | 1,962,000USD |
| Property Plant Equipment Gross | — | 1,774,000USD | 2,031,000USD | 2,104,000USD | 2,354,000USD | 688,000USD | 845,000USD | 544,000USD |
| Common Stock Shares Outstanding | — | 60,717,041shares | 55,142,252shares | 54,563,864shares | 54,539,230shares | 54,456,515shares | 54,440,013shares | 54,409,708shares |
| Non Current Assets Total | — | 8,684,000USD | 8,941,000USD | 127,316,000USD | 9,196,000USD | 7,323,000USD | 66,662,000USD | 2,659,000USD |
| Non Current Liabilities Total | — | 301,000USD | 593,000USD | 880,000USD | 1,164,000USD | 0USD | 59,330,000USD | 137,000USD |
| Non Currrent Assets Other | — | 6,910,000USD | 6,910,000USD | 7,795,000USD | 6,842,000USD | 6,635,000USD | 6,618,000USD | 2,115,000USD |
| Net Working Capital | — | 505,575,000USD | 393,104,000USD | 276,344,000USD | 427,164,000USD | 451,634,000USD | 484,543,000USD | 507,033,000USD |
| Unclassified Equity | — | 929,362,000USD | 760,411,000USD | 724,482,000USD | 720,432,000USD | 716,805,000USD | 712,877,000USD | 709,600,000USD |
| Long Term Investments | — | — | — | 117,417,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | 1,164,000USD | — | 59,330,000USD | — |
| Other Assets | — | — | — | — | — | — | -59,199,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | — | 59,199,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 430,994,000USD | 569,195,000USD | 233,982,000USD | 6,703,000USD |
| Other Current Assets | 7,252,000USD | 12,822,000USD | 633,000USD | 826,000USD |
| Total Liab | 29,542,000USD | 77,320,000USD | 15,474,000USD | 23,981,000USD |
| Total Stockholder Equity | 401,452,000USD | 491,875,000USD | 218,508,000USD | -17,278,000USD |
| Other Current Liab | 22,317,000USD | 12,875,000USD | 11,614,000USD | 18,759,000USD |
| Capital Stock | 7,000USD | 7,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -358,966,000USD | -221,016,000USD | -153,021,000USD | -101,036,000USD |
| Cash | 96,685,000USD | 489,711,000USD | 230,440,000USD | 4,158,000USD |
| Cash And Short Term Investments | 414,801,000USD | 489,711,000USD | 230,440,000USD | 4,158,000USD |
| Total Current Assets | 422,053,000USD | 502,533,000USD | 231,073,000USD | 4,984,000USD |
| Total Current Liabilities | 28,949,000USD | 17,990,000USD | 15,085,000USD | 23,896,000USD |
| Net Debt | -94,975,000USD | -488,973,000USD | -229,783,000USD | -4,158,000USD |
| Short Term Debt | 1,117,000USD | 607,000USD | 285,000USD | — |
| Short Long Term Debt Total | 1,710,000USD | 738,000USD | 657,000USD | — |
| Short Term Investments | 318,116,000USD | 0USD | — | — |
| Accounts Payable | 5,515,000USD | 4,508,000USD | 3,186,000USD | 5,137,000USD |
| Property Plant Equipment Net | 2,031,000USD | 845,000USD | 815,000USD | 636,000USD |
| Property Plant Equipment Gross | 2,031,000USD | 845,000USD | 815,000USD | 636,000USD |
| Common Stock Shares Outstanding | 54,676,896shares | 54,424,861shares | 51,760,925shares | 51,760,925shares |
| Non Current Assets Total | 8,941,000USD | 66,662,000USD | 2,909,000USD | 1,719,000USD |
| Non Current Liabilities Total | 593,000USD | 59,330,000USD | 389,000USD | 85,000USD |
| Non Currrent Assets Other | 6,910,000USD | 6,618,000USD | 2,094,000USD | 1,083,000USD |
| Net Working Capital | 393,104,000USD | 484,543,000USD | 215,988,000USD | -18,912,000USD |
| Unclassified Equity | 760,411,000USD | 712,877,000USD | 371,525,000USD | 83,754,000USD |
| Common Stock | — | 7,000USD | 2,000USD | 2,000USD |
| Unclassified Non Current Assets | — | 59,199,000USD | — | — |
| Unclassified Non Current Liabilities | — | 59,330,000USD | — | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD |
| Non Current Liabilities Other | — | — | 17,000USD | 85,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -56,211,000USD | -37,386,000USD | -36,330,000USD | -27,388,000USD | -36,846,000USD | -20,957,000USD | -17,481,000USD | -17,049,000USD |
| Depreciation | 382,000USD | 312,000USD | 24,000USD | 19,000USD | 19,000USD | 15,000USD | 15,000USD | 13,000USD |
| Stock Based Compensation | 5,858,000USD | 4,449,000USD | 3,614,000USD | 3,492,000USD | 3,451,000USD | 3,181,000USD | 2,031,000USD | 1,038,000USD |
| Other Non Cash Items | 6,513,000USD | 297,000USD | 281,000USD | 211,000USD | 138,000USD | -276,000USD | 68,000USD | 66,000USD |
| Change In Working Capital | 12,190,000USD | 8,442,000USD | 3,163,000USD | -1,928,000USD | 5,132,000USD | -11,995,000USD | -1,857,000USD | 3,024,000USD |
| Total Cash From Operating Activities | -37,508,000USD | -23,886,000USD | -29,248,000USD | -25,594,000USD | -28,106,000USD | -30,032,000USD | -17,224,000USD | -12,908,000USD |
| Capital Expenditures | -60,000USD | -238,000USD | -42,000USD | 0USD | 0USD | -40,000USD | -8,000USD | -19,000USD |
| Free Cash Flow | -37,568,000USD | -24,124,000USD | -29,290,000USD | -25,594,000USD | -28,106,000USD | -30,072,000USD | -17,232,000USD | -12,927,000USD |
| Investments | 101,000,000USD | -82,094,000USD | -236,121,000USD | 0USD | 0USD | -40,000USD | -8,000USD | -19,000USD |
| Total Cashflows From Investing Activities | 100,940,000USD | -82,332,000USD | -236,121,000USD | — | — | -40,000USD | -8,000USD | -19,000USD |
| Total Cash From Financing Activities | 163,345,000USD | 31,230,000USD | 436,000USD | 135,000USD | 460,000USD | -975,000USD | 334,135,000USD | 734,000USD |
| Issuance Of Capital Stock | 161,763,000USD | 29,498,000USD | — | — | 0USD | -1,052,000USD | 333,479,000USD | — |
| Change In Cash | 226,777,000USD | -74,988,000USD | -264,933,000USD | -25,459,000USD | -27,646,000USD | -31,047,000USD | 316,903,000USD | 203,855,000USD |
| Begin Period Cash Flow | 96,685,000USD | 171,673,000USD | 436,606,000USD | 462,065,000USD | 489,711,000USD | 520,758,000USD | 203,855,000USD | 216,048,000USD |
| End Period Cash Flow | 323,462,000USD | 96,685,000USD | 171,673,000USD | 436,606,000USD | 462,065,000USD | 489,711,000USD | 520,758,000USD | 203,855,000USD |
| Other Cashflows From Financing Activities | 163,345,000USD | 31,230,000USD | 436,000USD | — | 460,000USD | 77,000USD | 334,135,000USD | 435,500USD |
| Unclassified Operating Cash Flow | -6,240,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -161,763,000USD | -29,498,000USD | — | — | — | — | -333,479,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | -7,500USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -137,950,000USD | -67,995,000USD | -51,985,000USD | -37,845,000USD |
| Depreciation | 406,000USD | 56,000USD | 19,000USD | 10,000USD |
| Stock Based Compensation | 15,006,000USD | 7,397,000USD | 1,899,000USD | 810,000USD |
| Other Non Cash Items | 895,000USD | -77,000USD | 14,063,000USD | 5,871USD |
| Change In Working Capital | 14,809,000USD | -14,132,000USD | -9,624,000USD | 4,949,000USD |
| Total Cash From Operating Activities | -106,834,000USD | -74,751,000USD | -45,628,000USD | -32,076,000USD |
| Capital Expenditures | -280,000USD | -71,000USD | -586,000USD | -192,000USD |
| Free Cash Flow | -107,114,000USD | -74,822,000USD | -46,214,000USD | -32,268,000USD |
| Investments | -318,173,000USD | -9,000USD | -586,000USD | -192,000USD |
| Total Cashflows From Investing Activities | -318,453,000USD | -9,000USD | -586,000USD | -192,000USD |
| Total Cash From Financing Activities | 32,261,000USD | 334,031,000USD | 272,496,000USD | 31,695,000USD |
| Issuance Of Capital Stock | 29,498,000USD | 332,427,000USD | 272,347,000USD | 31,535,000USD |
| Change In Cash | -393,026,000USD | 259,271,000USD | 226,282,000USD | -573,000USD |
| Begin Period Cash Flow | 489,711,000USD | 230,440,000USD | 4,158,000USD | 4,731,000USD |
| End Period Cash Flow | 96,685,000USD | 489,711,000USD | 230,440,000USD | 4,158,000USD |
| Other Cashflows From Financing Activities | 32,261,000USD | 1,604,000USD | 272,496,000USD | 31,695,000USD |
| Unclassified Financing Cash Flow | -29,498,000USD | — | -272,347,000USD | -31,535,000USD |
| Other Cashflows From Investing Activities | — | 62,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.